Sickle Cell Therapy
![FDA Sets December Deadline for Vertex and CRISPR's Sickle Cell Therapy](https://pharmtales.com/wp-content/uploads/2023/06/FDA-Sets-December-Deadline-for-Vertex-and-CRISPRs-Sickle-Cell-Therapy.jpg)
FDA Sets December Deadline for Vertex and CRISPR’s Sickle Cell Therapy
SG Tylor
The US Food and Drug Administration (FDA) has initiated a priority review of exagamglogene autotemcel (exa-cel), a therapy developed by ...
The US Food and Drug Administration (FDA) has initiated a priority review of exagamglogene autotemcel (exa-cel), a therapy developed by ...